Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short-course amoxicillin versus 10-day treatment for pediatric acute streptococcal pharyngitis
2021-004143-24Phase 3Active
- Sponsor
- Hospital Universitario Niño Jesús
- Start
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of amoxicillin in streptococcal pharyngitis (3 arms), sponsored by Hospital Universitario Niño Jesús. Primary endpoint: Relapse. Started Mar 2022; status: active.
02
Drugs
amoxicillin
03
Conditions
streptococcal pharyngitis
Beyond the preview
Go deeper on 2021-004143-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-004143-24.